Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6]. Go to Publication You Might Also Like “Chennai Declaration”: 5-year plan to tackle the challenge of anti-microbial resistance. July 17, 2014 Review series: the politics of TB: the politics, economics and impact of directly observed treatment (DOT) in India. September 19, 2007 A 12-year-old girl with Hodgkin’s disease presenting as a non-resolving pneumonia and an endobronchial nodule. November 15, 2009 Response to Dr Daley’s article: Do not ignore the private sector. January 12, 2015 Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. April 20, 2014
“Chennai Declaration”: 5-year plan to tackle the challenge of anti-microbial resistance. July 17, 2014
Review series: the politics of TB: the politics, economics and impact of directly observed treatment (DOT) in India. September 19, 2007
A 12-year-old girl with Hodgkin’s disease presenting as a non-resolving pneumonia and an endobronchial nodule. November 15, 2009
Global control of tuberculosis: from extensively drug-resistant to untreatable tuberculosis. April 20, 2014